Altai Capital Management L.P. Has $12.03 Million Stake in OraSure Technologies, Inc. $OSUR

Altai Capital Management L.P. lifted its holdings in OraSure Technologies, Inc. (NASDAQ:OSUR) by 73.4% during the 3rd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 3,748,836 shares of the medical instruments supplier’s stock after acquiring an additional 1,586,488 shares during the period. OraSure Technologies makes up approximately 23.6% of Altai Capital Management L.P.’s investment portfolio, making the stock its 2nd largest position. Altai Capital Management L.P. owned about 5.23% of OraSure Technologies worth $12,034,000 at the end of the most recent quarter.

A number of other hedge funds have also bought and sold shares of OSUR. Prudential Financial Inc. acquired a new stake in OraSure Technologies in the 2nd quarter worth about $31,000. Nierenberg Investment Management Company Inc. acquired a new position in shares of OraSure Technologies during the 2nd quarter worth approximately $35,000. L2 Asset Management LLC acquired a new position in shares of OraSure Technologies during the 2nd quarter worth approximately $39,000. Coldstream Capital Management Inc. increased its holdings in shares of OraSure Technologies by 128.2% during the second quarter. Coldstream Capital Management Inc. now owns 13,308 shares of the medical instruments supplier’s stock worth $40,000 after purchasing an additional 7,477 shares during the period. Finally, Amundi acquired a new stake in shares of OraSure Technologies in the first quarter valued at approximately $47,000. 93.50% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings reiterated a “sell (d)” rating on shares of OraSure Technologies in a research note on Thursday, January 22nd. Two analysts have rated the stock with a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, the company has a consensus rating of “Reduce” and a consensus price target of $3.00.

OraSure Technologies Stock Down 3.9%

OSUR opened at $2.97 on Friday. OraSure Technologies, Inc. has a twelve month low of $2.08 and a twelve month high of $4.22. The company has a 50-day simple moving average of $2.81 and a 200 day simple moving average of $2.80. The stock has a market capitalization of $205.30 million, a price-to-earnings ratio of -3.19 and a beta of 0.88.

OraSure Technologies (NASDAQ:OSUR) last announced its quarterly earnings data on Wednesday, February 25th. The medical instruments supplier reported ($0.19) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.17) by ($0.02). OraSure Technologies had a negative return on equity of 16.45% and a negative net margin of 59.76%.The firm had revenue of $26.76 million for the quarter, compared to analyst estimates of $26.44 million. Sell-side analysts anticipate that OraSure Technologies, Inc. will post -0.08 EPS for the current fiscal year.

OraSure Technologies Profile

OraSure Technologies, Inc is a Bethlehem, Pennsylvania–based diagnostic and medical device company specializing in the development, manufacture and commercialization of point-of-care and self-testing products. Founded in 1988, OraSure has built a portfolio of oral fluid and other non-invasive specimen collection technologies that support the detection of infectious diseases, drugs of abuse, and health and wellness biomarkers.

The company’s flagship product, the OraQuick® rapid HIV test, was the first Food and Drug Administration–approved over-the-counter oral fluid test for the detection of HIV-1/2 antibodies.